Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-06

FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories, LLC's eslicarbazepine acetate as an original generic application. It is indicated as adjunctive therapy for adults with pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)